SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-22-011927
Filing Date
2022-07-05
Accepted
2022-07-05 08:25:53
Documents
16
Period of Report
2022-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp176668_8k.htm   iXBRL 8-K 35051
2 EXHIBIT 2.1 dp176668_ex0201.htm EX-2.1 541199
3 EXHIBIT 2.2 dp176668_ex0202.htm EX-2.2 20722
4 EXHIBIT 99.1 dp176668_ex9901.htm EX-99.1 13054
5 GRAPHIC image_001.jpg GRAPHIC 38387
  Complete submission text file 0000950103-22-011927.txt   958664

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pgen-20220701.xsd EX-101.SCH 3076
7 XBRL LABEL FILE pgen-20220701_lab.xml EX-101.LAB 34476
8 XBRL PRESENTATION FILE pgen-20220701_pre.xml EX-101.PRE 22585
10 EXTRACTED XBRL INSTANCE DOCUMENT dp176668_8k_htm.xml XML 3477
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 221063254
SIC: 2834 Pharmaceutical Preparations